Factors associated with mortality in Infections caused by Carbapenem-resistant Enterobacteriaceae

Introduction: There is little information about weigh of factors possibly associated with mortality, in infections caused by Carbapenem-resistant Enterobacteriaceae (CRE) in Latin America. Methodology: A case-controls study nested in a historical cohort was performed including all patients with CRE infections diagnosed between June 2013 and December 2018 at Hospital Universitario San Ignacio in Bogotá, Colombia. Univariate and multivariate analysis were performed to compare cases of mortality within the first month after the infection diagnosis with surviving patients. Results: A total of 131 patients were included. The overall 30-day mortality rate was 38.17%. In the multivariate analysis, a direct association was found between mortality and septic shock (OR 26.7 CI6.6-107.3 p < 0.01), post-chemotherapy febrile neutropenia (OR 3.3 CI1.06–10.8 p = 0.04) and Charlson Index ≥ 3 (OR 5.5 CI 1.5-20.06 p < 0.01). An inverse association was found with interventions to control the infectious focus (OR 0.3 CI0.1-0.7 p < 0.01). The MIC of different antibiotics and the use of combined antibiotic therapy (triple therapy vs. double therapy or monotherapy) were not associated with mortality. Conclusions: In patients with CRE infections, septic shock, a Charlson comorbidity index ≥ 3, and post-chemotherapy febrile neutropenia are independently related to an increase in mortality. The control of the infectious focus is a protective factor. A rapid identification of these patients, and the implementation of measures to control infectious focus and to detect CRE colonization in patients who are going to be taken to myelosuppressive chemotherapy could impact positively the prognosis of these patients.

• Autores: Gualtero Trujillo, Sandra Milena; Valderrama Beltran, Sandra Liliana; Valencia, Margarita; Rueda, Diana; Muñoz Velandia, Oscar Mauricio; Ariza, Beatriz; Cortes, Gloria; Salgado, Diana; Porras, Yuly; Niño, Angie
• Tipo de recurso: Article of journal
• Fecha de publicación: 2020
• Institución: Pontificia Universidad Javeriana
• Repositorio: Repositorio Universidad Javeriana
• Idioma: eng
• OAI Identifier: oai:repository.javeriana.edu.co:10554/60178
• Acceso en línea: https://jidc.org/index.php/journal/article/view/12267; http://hdl.handle.net/10554/60178; https://doi.org/10.3855/jidc.12267
• Palabra clave: Carbapenemase; carbapenem resistance; combination therapy; meropenem MICs; Carbapenemase; carbapenem resistance; combination therapy; meropenem MICs
• License: Atribución-NoComercial 4.0 Internacional